Legal Guidelines for Documentation
Strategies for Assessing and Addressing Confounding
Bioequivalence studies: Biowaivers
Transmission-based Precautions II: Airborne and Protective Environment
Methods of Documentation V: CBE
Actuarial Approach
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 7, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
1Neiswanger Institute for Bioethics and Health Policy, Stritch School of Medicine, Loyola University Chicago, USA.
No abstract available in PubMed .